NCT07896720Not yet recruiting
Remote Robotic Surgery for Gynecologic Cancer: A Safety and Effectiveness Study
A Multicenter, Single-Blind, Randomized Controlled Study on the Safety and Efficacy of Remote Robotic Surgery for Gynecologic Malignancies
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
This investigator-initiated, multicenter, single-blind, randomized controlled clinical study is designed to evaluate the safety and effectiveness of the MP2000 thoracoabdominal endoscopic surgical system (Shenzhen Jingfeng Medical Technology Co., Ltd.) when used for remote robotic surgery in patients with gynecologic malignancies. By comparing remote robotic surgery with local robotic surgery, the study will assess clinical outcomes including postoperative recovery, the incidence of complications, and the length of hospital stay, thereby providing clinical evidence on the safety and efficacy of remote robotic surgery versus conventional local robotic surgery.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- First submitted
- 8 Oct 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 1 Sept 2029
- Lead sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Diseases
- Endometrial cancer, Cervical cancer
- NCT number
- NCT07896720
What you commit to
- Study type: Interventional
- Planned participants: 92
- From 1 Oct 2026 to the primary completion date, 1 Sept 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cardiovascular or circulatory disease that makes surgery intolerable. Fertility-sparing requirement. Pregnancy or lactation. History of epilepsy or psychiatric disorders. Severe allergic constitution, or suspected or confirmed alcohol or drug addiction.
- Inability to understand study requirements or complete the follow-up schedule. Any other condition deemed unsuitable for participation by the investigator.
Who the study is looking for
- Cervical cancer: aged 18 to 70 years; or endometrial cancer: aged 18 to 80 years.
- BMI: 18 to 40 kg/m². Histopathologically confirmed endometrial cancer or cervical cancer with an indication for surgery.
- Physiologically suitable for laparoscopic surgery. Willing to comply with and complete study follow-up and related examinations. Voluntary signing of the informed consent form.
Age in the registry: 18 years to 80 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.